♥
ISIN : INE579C01029
NSE : VIMTALABS
BSE : 524394
Face Value : 2
Industry : Miscellaneous
EPS : 18.24
EPS (TTM) : 18.31
Price to Earning (P/E) : 55.07
Book Value : 141.18
Price to Bookvalue (P/B) : 7.12
Dividend Yield : 0 %
Return on Equity (ROE) : 13.94 %
Return on Capital Employed (ROCE) : 17.81 %
Vimta Labs Limited
ISIN : INE579C01029
NSE : VIMTALABS
BSE : 524394
Face Value : 2
Industry : Miscellaneous
EPS : 18.24
EPS (TTM) : 18.31
Price to Earning (P/E) : 55.07
Book Value : 141.18
Price to Bookvalue (P/B) : 7.12
Dividend Yield : 0 %
Return on Equity (ROE) : 13.94 %
Return on Capital Employed (ROCE) : 17.81 %
Vimta Labs share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 390.05 - 409.15 4.9 % |
| Low / High | 390.05 - 412.1 5.7 % |
| Trade Volume | 6,554 |
| 52 Week Low / High | 377.3 - 1093.7 189.9 % |
-
YOU MAY ALSO LIKE
- High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Stock market course tutorial
Stock Market Investment Course explained in simple words. - Share Market basics for beginners
Share Market jargons in simple terms - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
CONSOLIDATED QUARTERLY RESULT FOR VIMTA LABS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 740.88 | 791.32 | 798.54 | 773.84 | 818.2 | 834.85 | 734.09 | 816.79 | 796.88 | 817.55 |
| Total Income | 745.27 | 800.23 | 806.16 | 785.08 | 824.87 | 840.73 | 754.45 | 825.74 | 801.76 | 824.46 |
| Total Expenditure | 510.41 | 552.25 | 544.81 | 559.29 | 576.44 | 588.35 | 575.25 | 598.4 | 552.7 | 572.34 |
| Other Income | 4.39 | 8.91 | 7.62 | 11.24 | 6.67 | 5.88 | 20.36 | 8.95 | 4.88 | 6.91 |
| Operating Profit | 234.86 | 247.98 | 261.35 | 225.79 | 248.43 | 252.38 | 179.2 | 227.34 | 249.06 | 252.12 |
| Interest | 5.75 | 9.44 | 8 | 6.53 | 2.48 | 4.4 | 6.15 | 5.36 | 5.31 | 4.77 |
| PBDT | 229.11 | 238.54 | 253.35 | 219.26 | 245.95 | 247.98 | 173.05 | 221.98 | 243.75 | 247.35 |
| Depreciation | 66.85 | 72.5 | 75.75 | 78.47 | 80.41 | 84.95 | 89.16 | 86.93 | 80.91 | 82.12 |
| Profit Before Tax | 162.26 | 166.04 | 177.6 | 140.79 | 165.54 | 163.03 | 83.89 | 135.05 | 162.84 | 165.23 |
| Tax | 43.92 | 45.67 | 45.49 | 38.38 | 38.71 | 41.05 | 20.61 | 33.73 | 39.33 | 42.43 |
| Profit After Tax | 118.34 | 120.37 | 132.11 | 102.41 | 126.83 | 121.98 | 63.28 | 101.32 | 123.51 | 122.8 |
| Net Profit | 118.34 | 120.37 | 132.11 | 102.41 | 126.83 | 121.98 | 63.28 | 101.32 | 123.51 | 122.8 |
| Equity Capital | 44.22 | 44.22 | 44.22 | 44.25 | 44.26 | 44.28 | 44.29 | 44.33 | 44.34 | 44.34 |
| Face Value (IN RS) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Calculated EPS | 5.35 | 5.44 | 5.98 | 4.63 | 5.73 | 5.51 | 2.86 | 4.57 | 5.57 | 5.54 |
| Diluted Eps After Extraordinary Items | 5.28 | 5.34 | 5.85 | 4.51 | 5.64 | 5.4 | 2.83 | 4.5 | 5.51 | 5.47 |
| Diluted Eps Before Extraordinary Items | 5.28 | 5.34 | 5.85 | 4.51 | 5.64 | 5.4 | 2.83 | 4.5 | 5.51 | 5.47 |
STANDALONE QUARTERLY RESULT FOR VIMTA LABS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 735.99 | 786.84 | 791.32 | 764.97 | 808.03 | 821.93 | 722.63 | 800.97 | 783.38 | 801.99 |
| Total Income | 740.18 | 795.84 | 799.03 | 776.29 | 814.68 | 827.86 | 743.01 | 809.89 | 788.25 | 808.9 |
| Total Expenditure | 505.27 | 548.38 | 540.1 | 554.77 | 572.44 | 583.58 | 569.65 | 592.15 | 547.14 | 566 |
| Other Income | 4.19 | 9 | 7.71 | 11.32 | 6.65 | 5.93 | 20.38 | 8.92 | 4.87 | 6.91 |
| Operating Profit | 234.91 | 247.46 | 258.93 | 221.52 | 242.24 | 244.28 | 173.36 | 217.74 | 241.11 | 242.9 |
| Interest | 5.74 | 9.44 | 7.99 | 6.53 | 2.48 | 4.38 | 6.15 | 5.32 | 5.28 | 4.77 |
| PBDT | 229.17 | 238.02 | 250.94 | 214.99 | 239.76 | 239.9 | 167.21 | 212.42 | 235.83 | 238.13 |
| Depreciation | 66.44 | 72.07 | 75.32 | 78.03 | 79.98 | 84.51 | 88.72 | 86.44 | 80.32 | 81.46 |
| Profit Before Tax | 162.73 | 165.95 | 175.62 | 136.96 | 159.78 | 155.39 | 78.49 | 125.98 | 155.51 | 156.67 |
| Tax | 43.97 | 45.65 | 44.99 | 37.4 | 37.28 | 39.11 | 19.26 | 31.43 | 37.5 | 40.28 |
| Profit After Tax | 118.76 | 120.3 | 130.63 | 99.56 | 122.5 | 116.28 | 59.23 | 94.55 | 118.01 | 116.39 |
| Net Profit | 118.76 | 120.3 | 130.63 | 99.56 | 122.5 | 116.28 | 59.23 | 94.55 | 118.01 | 116.39 |
| Equity Capital | 44.22 | 44.22 | 44.22 | 44.25 | 44.26 | 44.28 | 44.29 | 44.33 | 44.34 | 44.34 |
| Face Value (IN RS) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Calculated EPS | 5.37 | 5.44 | 5.91 | 4.5 | 5.54 | 5.25 | 2.67 | 4.27 | 5.32 | 5.25 |
| Diluted Eps After Extraordinary Items | 5.3 | 5.33 | 5.8 | 4.39 | 5.45 | 5.15 | 2.65 | 4.2 | 5.26 | 5.18 |
| Diluted Eps Before Extraordinary Items | 5.3 | 5.33 | 5.8 | 4.39 | 5.45 | 5.15 | 2.65 | 4.2 | 5.26 | 5.18 |
CONSOLIDATED ANNUAL RESULT FOR VIMTA LABS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 2782.79 | 3181.9 | 3182.61 |
| Total Income | 2797.28 | 3216.34 | 3222.68 |
| Total Expenditure | 1979.92 | 2232.79 | 2314.7 |
| Other Income | 14.49 | 34.44 | 40.07 |
| Operating Profit | 817.36 | 983.55 | 907.98 |
| Interest | 14.98 | 26.45 | 21.22 |
| Exceptional Items | -12.24 | ||
| PBDT | 790.14 | 957.1 | 886.76 |
| Depreciation | 233.29 | 307.13 | 341.95 |
| Profit Before Tax | 556.85 | 649.97 | 544.81 |
| Tax | 143.55 | 168.25 | 134.72 |
| Profit After Tax | 413.3 | 481.72 | 410.09 |
| Net Profit | 413.3 | 481.72 | 410.09 |
| Equity Capital | 44.22 | 44.26 | 44.34 |
| Face Value (IN RS) | 2 | 2 | 2 |
| Reserves | 2295.62 | 2773.6 | 3152.62 |
| Calculated EPS | 18.69 | 21.77 | 18.5 |
| Diluted Eps After Extraordinary Items | 18.32 | 21.35 | 18.24 |
| Diluted Eps Before Extraordinary Items | 18.32 | 21.35 | 18.24 |
STANDALONE ANNUAL RESULT FOR VIMTA LABS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 2759.8 | 3151.16 | 3128.91 |
| Total Income | 2774.34 | 3185.84 | 3169.01 |
| Total Expenditure | 1962.08 | 2215.69 | 2292.52 |
| Other Income | 14.54 | 34.68 | 40.1 |
| Operating Profit | 812.26 | 970.15 | 876.49 |
| Interest | 14.96 | 26.44 | 21.13 |
| Exceptional Items | -12.24 | ||
| PBDT | 785.06 | 943.71 | 855.36 |
| Depreciation | 231.58 | 305.4 | 339.99 |
| Profit Before Tax | 553.48 | 638.31 | 515.37 |
| Tax | 142.9 | 165.32 | 127.3 |
| Profit After Tax | 410.58 | 472.99 | 388.07 |
| Net Profit | 410.58 | 472.99 | 388.07 |
| Equity Capital | 44.22 | 44.26 | 44.34 |
| Face Value (IN RS) | 2 | 2 | 2 |
| Reserves | 2292.27 | 2761.56 | 3118.57 |
| Calculated EPS | 18.57 | 21.37 | 17.5 |
| Diluted Eps After Extraordinary Items | 18.2 | 20.96 | 17.26 |
| Diluted Eps Before Extraordinary Items | 18.2 | 20.96 | 17.26 |
CONSOLIDATED PROFIT / LOSS FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 210.68 Cr | 278.28 Cr | 318.19 Cr | 318.26 Cr |
| Processing Charges / Service Income | 208.57 Cr | 275.94 Cr | 315.06 Cr | 318.26 Cr |
| Net Sales | 210.68 Cr | 278.28 Cr | 318.19 Cr | 318.26 Cr |
| Increase/Decrease in Stock | 2.98 Cr | 26.6 Lk | 11.1 Lk | 10.4 Lk |
| Power & Fuel Cost | 10.28 Cr | 11.36 Cr | 14.47 Cr | 13.24 Cr |
| Electricity & Power | 9.7 Cr | 10.72 Cr | 13.84 Cr | 12.57 Cr |
| Employee Cost | 57.8 Cr | 71.42 Cr | 86.32 Cr | 95.3 Cr |
| Salaries, Wages & Bonus | 51.32 Cr | 59.91 Cr | 73.24 Cr | 84.05 Cr |
| Contributions to EPF & Pension Funds | 2.6 Cr | 3.22 Cr | 3.39 Cr | 3.96 Cr |
| Workmen and Staff Welfare Expenses | 1.57 Cr | 2.13 Cr | 2.15 Cr | 2.44 Cr |
| Other Manufacturing Expenses | 57.77 Cr | 78.69 Cr | 72.53 Cr | 77.45 Cr |
| Repairs and Maintenance | 9.44 Cr | 10.59 Cr | 12.59 Cr | 13.81 Cr |
| General and Administration Expenses | 22.19 Cr | 27.51 Cr | 34.74 Cr | 32.24 Cr |
| Rent , Rates & Taxes | 5.61 Cr | 4.93 Cr | 6.08 Cr | 5.25 Cr |
| Insurance | 85.9 Lk | 79.8 Lk | 98.1 Lk | 84.9 Lk |
| Printing and stationery | 38.4 Lk | 2.08 Cr | 2.04 Cr | 2.08 Cr |
| Professional and legal fees | 4.82 Cr | 5.26 Cr | 7.04 Cr | 6.9 Cr |
| Traveling and conveyance | 3.49 Cr | 5.05 Cr | 8.02 Cr | 7.59 Cr |
| Selling and Distribution Expenses | 27.1 Lk | 2.16 Cr | 9.44 Cr | 7.49 Cr |
| Advertisement & Sales Promotion | 16.6 Lk | 29.8 Lk | 59.5 Lk | 69.8 Lk |
| Sales Commissions & Incentives | 10.5 Lk | 1.87 Cr | 8.84 Cr | 6.79 Cr |
| Miscellaneous Expenses | 6.42 Cr | 6.58 Cr | 5.67 Cr | 5.65 Cr |
| Bad debts /advances written off | 3.17 Cr | 4.45 Cr | 3.13 Cr | 2.95 Cr |
| Provision for doubtful debts | 0 | 1.31 Cr | 1.51 Cr | 94.2 Lk |
| Loss on disposal of fixed assets(net) | 1.7 Lk | 0 | 11.9 Lk | 0 |
| Loss on foreign exchange fluctuations | 43.1 Lk | 19.2 Lk | 0 | 10,000 |
| Total Expenditure | 157.72 Cr | 197.99 Cr | 223.28 Cr | 231.47 Cr |
| Other Income | 82.9 Lk | 1.45 Cr | 3.44 Cr | 4.01 Cr |
| Interest Received | 41.1 Lk | 83.1 Lk | 1.2 Cr | 1.34 Cr |
| Profit on sale of Fixed Assets | 0 | 4.2 Lk | 24.4 Lk | 56.5 Lk |
| Provision Written Back | 6 Lk | 8.7 Lk | 20,000 | 89.4 Lk |
| Foreign Exchange Gains | 0 | 0 | 1.09 Cr | 17.4 Lk |
| Operating Profit | 53.79 Cr | 81.74 Cr | 98.36 Cr | 90.8 Cr |
| Interest | 2.17 Cr | 1.5 Cr | 2.64 Cr | 2.12 Cr |
| Interest on Term Loan | 79.7 Lk | 65.9 Lk | 87 Lk | 1.25 Cr |
| Bank Charges etc | 44 Lk | 43 Lk | 44 Lk | 43.8 Lk |
| PBDT | 51.62 Cr | 80.24 Cr | 95.71 Cr | 88.68 Cr |
| Depreciation | 23.08 Cr | 23.33 Cr | 30.71 Cr | 34.2 Cr |
| Profit Before Taxation & Exceptional Items | 28.54 Cr | 56.91 Cr | 65 Cr | 54.48 Cr |
| Exceptional Income / Expenses | 0 | -1.22 Cr | 0 | 0 |
| Profit Before Tax | 28.54 Cr | 55.68 Cr | 65 Cr | 54.48 Cr |
| Provision for Tax | 7.14 Cr | 14.36 Cr | 16.82 Cr | 13.47 Cr |
| Current Income Tax | 7.63 Cr | 14.94 Cr | 18.37 Cr | 16.33 Cr |
| Deferred Tax | -49.1 Lk | -1.03 Cr | -2.24 Cr | -3.4 Cr |
| Profit After Tax | 21.4 Cr | 41.33 Cr | 48.17 Cr | 41.01 Cr |
| Consolidated Net Profit | 21.4 Cr | 41.33 Cr | 48.17 Cr | 41.01 Cr |
| Profit Balance B/F | 84.19 Cr | 105.59 Cr | 142.5 Cr | 186.25 Cr |
| Appropriations | 105.59 Cr | 146.92 Cr | 190.67 Cr | 227.26 Cr |
| Other Appropriation | 0 | 4.42 Cr | 4.42 Cr | 4.43 Cr |
| Equity Dividend % | 100 | 100 | 100 | 100 |
| Earnings Per Share | 9.68 | 18.69 | 21.77 | 18.5 |
| Adjusted EPS | 9.68 | 18.69 | 21.77 | 18.5 |
STANDALONE PROFIT / LOSS FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 209.05 Cr | 275.98 Cr | 275.98 Cr | 312.89 Cr |
| Processing Charges / Service Income | 206.94 Cr | 273.64 Cr | 273.64 Cr | 312.89 Cr |
| Net Sales | 209.05 Cr | 275.98 Cr | 275.98 Cr | 312.89 Cr |
| Increase/Decrease in Stock | 2.98 Cr | 26.6 Lk | 26.6 Lk | 10.4 Lk |
| Power & Fuel Cost | 10.24 Cr | 11.31 Cr | 11.31 Cr | 13.09 Cr |
| Electricity & Power | 9.66 Cr | 10.67 Cr | 10.67 Cr | 12.42 Cr |
| Employee Cost | 57.28 Cr | 70.85 Cr | 70.85 Cr | 94.51 Cr |
| Salaries, Wages & Bonus | 50.8 Cr | 59.4 Cr | 59.4 Cr | 83.28 Cr |
| Contributions to EPF & Pension Funds | 2.6 Cr | 3.21 Cr | 3.21 Cr | 3.95 Cr |
| Workmen and Staff Welfare Expenses | 1.57 Cr | 2.12 Cr | 2.12 Cr | 2.42 Cr |
| Other Manufacturing Expenses | 57.5 Cr | 78.23 Cr | 78.23 Cr | 76.76 Cr |
| Repairs and Maintenance | 9.4 Cr | 10.55 Cr | 10.55 Cr | 13.74 Cr |
| General and Administration Expenses | 21.72 Cr | 27 Cr | 27 Cr | 31.66 Cr |
| Rent , Rates & Taxes | 5.21 Cr | 4.54 Cr | 4.54 Cr | 4.84 Cr |
| Insurance | 85.7 Lk | 79.4 Lk | 79.4 Lk | 84.3 Lk |
| Printing and stationery | 37.8 Lk | 2.07 Cr | 2.07 Cr | 2.06 Cr |
| Professional and legal fees | 4.79 Cr | 5.2 Cr | 5.2 Cr | 6.85 Cr |
| Traveling and conveyance | 3.48 Cr | 5.04 Cr | 5.04 Cr | 7.54 Cr |
| Selling and Distribution Expenses | 24.8 Lk | 2.13 Cr | 2.13 Cr | 7.49 Cr |
| Advertisement & Sales Promotion | 14.3 Lk | 25.9 Lk | 25.9 Lk | 69.8 Lk |
| Sales Commissions & Incentives | 10.5 Lk | 1.87 Cr | 1.87 Cr | 6.79 Cr |
| Miscellaneous Expenses | 6.39 Cr | 6.43 Cr | 6.43 Cr | 5.65 Cr |
| Bad debts /advances written off | 3.17 Cr | 4.3 Cr | 4.3 Cr | 2.95 Cr |
| Provision for doubtful debts | 0 | 1.31 Cr | 1.31 Cr | 94.2 Lk |
| Loss on disposal of fixed assets(net) | 1.7 Lk | 0 | 0 | 0 |
| Loss on foreign exchange fluctuations | 43.1 Lk | 19.2 Lk | 19.2 Lk | 0 |
| Total Expenditure | 156.36 Cr | 196.21 Cr | 196.21 Cr | 229.25 Cr |
| Other Income | 81 Lk | 1.45 Cr | 1.45 Cr | 4.01 Cr |
| Interest Received | 42 Lk | 87 Lk | 87 Lk | 1.35 Cr |
| Profit on sale of Fixed Assets | 0 | 4.2 Lk | 4.2 Lk | 56.5 Lk |
| Provision Written Back | 3.2 Lk | 5.3 Lk | 5.3 Lk | 89.4 Lk |
| Foreign Exchange Gains | 0 | 0 | 0 | 17.4 Lk |
| Operating Profit | 53.5 Cr | 81.23 Cr | 81.23 Cr | 87.65 Cr |
| Interest | 2.17 Cr | 1.5 Cr | 1.5 Cr | 2.11 Cr |
| Interest on Term Loan | 79.7 Lk | 65.9 Lk | 65.9 Lk | 1.25 Cr |
| Bank Charges etc | 43.9 Lk | 42.8 Lk | 42.8 Lk | 42.9 Lk |
| PBDT | 51.33 Cr | 79.73 Cr | 79.73 Cr | 85.54 Cr |
| Depreciation | 22.94 Cr | 23.16 Cr | 23.16 Cr | 34 Cr |
| Profit Before Taxation & Exceptional Items | 28.4 Cr | 56.57 Cr | 56.57 Cr | 51.54 Cr |
| Exceptional Income / Expenses | 0 | -1.22 Cr | -1.22 Cr | 0 |
| Profit Before Tax | 28.4 Cr | 55.35 Cr | 55.35 Cr | 51.54 Cr |
| Provision for Tax | 7.14 Cr | 14.29 Cr | 14.29 Cr | 12.73 Cr |
| Current Income Tax | 7.63 Cr | 14.88 Cr | 14.88 Cr | 15.6 Cr |
| Deferred Tax | -48.9 Lk | -1.03 Cr | -1.03 Cr | -3.41 Cr |
| Profit After Tax | 21.26 Cr | 41.06 Cr | 41.06 Cr | 38.81 Cr |
| Consolidated Net Profit | 21.26 Cr | 41.06 Cr | 41.06 Cr | 38.81 Cr |
| Profit Balance B/F | 84.27 Cr | 105.53 Cr | 105.53 Cr | 185.04 Cr |
| Appropriations | 105.53 Cr | 146.59 Cr | 146.59 Cr | 223.85 Cr |
| Other Appropriation | 0 | 4.42 Cr | 4.42 Cr | 4.43 Cr |
| Equity Dividend % | 100 | 100 | 100 | 100 |
| Earnings Per Share | 9.62 | 18.57 | 18.57 | 17.5 |
| Adjusted EPS | 9.62 | 18.57 | 18.57 | 17.5 |
CONSOLIDATED CASH FLOW FOR VIMTA LABS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 28.54 Cr | 55.68 Cr | 65 Cr | 54.48 Cr |
| Adjustment | 29.49 Cr | 28.48 Cr | 39.11 Cr | 37.26 Cr |
| Changes In working Capital | -13.64 Cr | -8.46 Cr | -3.64 Cr | -15.38 Cr |
| Cash Flow after changes in Working Capital | 44.39 Cr | 75.71 Cr | 100.47 Cr | 76.36 Cr |
| Cash Flow from Operating Activities | 37.18 Cr | 59.07 Cr | 87.94 Cr | 60.89 Cr |
| Cash Flow from Investing Activities | -31.92 Cr | -37.85 Cr | -57.26 Cr | -76.05 Cr |
| Cash Flow from Financing Activitie | -4.57 Cr | -16.61 Cr | -10.98 Cr | -1.9 Cr |
| Net Cash Inflow / Outflow | 68.8 Lk | 4.61 Cr | 19.7 Cr | -17.06 Cr |
| Opening Cash & Cash Equivalents | 5.5 Cr | 6.19 Cr | 10.8 Cr | 30.5 Cr |
| Closing Cash & Cash Equivalent | 6.19 Cr | 10.8 Cr | 30.5 Cr | 13.44 Cr |
STANDALONE CASH FLOW FOR VIMTA LABS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 28.4 Cr | 55.35 Cr | 55.35 Cr | 51.54 Cr |
| Adjustment | 29.35 Cr | 28.31 Cr | 28.31 Cr | 37.06 Cr |
| Changes In working Capital | -13.57 Cr | -8.42 Cr | -8.42 Cr | -14.73 Cr |
| Cash Flow after changes in Working Capital | 44.18 Cr | 75.24 Cr | 75.24 Cr | 73.87 Cr |
| Cash Flow from Operating Activities | 36.97 Cr | 58.67 Cr | 58.67 Cr | 59.06 Cr |
| Cash Flow from Investing Activities | -31.87 Cr | -37.88 Cr | -37.88 Cr | -74.6 Cr |
| Cash Flow from Financing Activitie | -4.57 Cr | -16.14 Cr | -16.14 Cr | -1.9 Cr |
| Net Cash Inflow / Outflow | 52.7 Lk | 4.64 Cr | 4.64 Cr | -17.45 Cr |
| Opening Cash & Cash Equivalents | 5.48 Cr | 6.01 Cr | 6.01 Cr | 29.57 Cr |
| Closing Cash & Cash Equivalent | 6.01 Cr | 10.65 Cr | 10.65 Cr | 12.13 Cr |
CONSOLIDATED BALANCE SHEET FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 4.42 Cr | 4.42 Cr | 4.43 Cr | 4.43 Cr |
| Equity - Authorised | 7 Cr | 7 Cr | 7 Cr | 7 Cr |
| Equity - Issued | 4.42 Cr | 4.42 Cr | 4.43 Cr | 4.43 Cr |
| Equity Paid Up | 4.42 Cr | 4.42 Cr | 4.43 Cr | 4.43 Cr |
| Face Value | 2 | 2 | 2 | 2 |
| Total Reserves | 189.96 Cr | 226.66 Cr | 271 Cr | 308.56 Cr |
| Securities Premium | 77.37 Cr | 77.37 Cr | 77.99 Cr | 79.19 Cr |
| Profit & Loss Account Balance | 105.59 Cr | 142.5 Cr | 186.25 Cr | 222.83 Cr |
| General Reserves | 8.64 Cr | 8.64 Cr | 8.64 Cr | 8.64 Cr |
| Reserve excluding Revaluation Reserve | 189.96 Cr | 226.66 Cr | 271 Cr | 308.56 Cr |
| Shareholder's Funds | 194.38 Cr | 233.98 Cr | 281.79 Cr | 319.7 Cr |
| Secured Loans | 13.08 Cr | 12.27 Cr | 9.68 Cr | 9.07 Cr |
| Term Loans - Banks | 19.01 Cr | 17.91 Cr | 14.46 Cr | 13.84 Cr |
| Term Loans - Institutions | 1.26 Cr | 26.2 Lk | 0 | 0 |
| Unsecured Loans | 1.15 Cr | 39 Lk | 20.9 Lk | 0 |
| Loans - Others | 1.15 Cr | 84.5 Lk | 53.1 Lk | 0 |
| Deferred Tax Assets / Liabilities | -89.6 Lk | -1.99 Cr | -4.24 Cr | -7.72 Cr |
| Deferred Tax Assets | 3.89 Cr | 4.71 Cr | 5.93 Cr | 7.81 Cr |
| Deferred Tax Liability | 3 Cr | 2.72 Cr | 1.68 Cr | 9.2 Lk |
| Other Long Term Liabilities | 3.84 Cr | 5.58 Cr | 4.52 Cr | 5.33 Cr |
| Long Term Provisions | 7.92 Cr | 7.15 Cr | 8.78 Cr | 11.8 Cr |
| Total Non-Current Liabilities | 25.1 Cr | 23.4 Cr | 18.95 Cr | 18.49 Cr |
| Trade Payables | 14.83 Cr | 12.34 Cr | 14.44 Cr | 8.23 Cr |
| Sundry Creditors | 14.83 Cr | 12.34 Cr | 14.44 Cr | 8.23 Cr |
| Other Current Liabilities | 26.49 Cr | 31.52 Cr | 38.88 Cr | 37.29 Cr |
| Advances received from customers | 4.14 Cr | 4.78 Cr | 4.9 Cr | 4.87 Cr |
| Interest Accrued But Not Due | 5.4 Lk | 60,000 | 0 | 0 |
| Short Term Borrowings | 9 Cr | 31.9 Lk | 0 | 5.14 Cr |
| Secured ST Loans repayable on Demands | 9 Cr | 31.9 Lk | 0 | 5.14 Cr |
| Working Capital Loans- Sec | 8.21 Cr | 31.9 Lk | 0 | 5.14 Cr |
| Short Term Provisions | 3.59 Cr | 3.57 Cr | 3.96 Cr | 3.4 Cr |
| Total Current Liabilities | 53.91 Cr | 47.75 Cr | 57.28 Cr | 54.07 Cr |
| Total Liabilities | 273.39 Cr | 305.13 Cr | 358.01 Cr | 392.25 Cr |
| Gross Block | 223.43 Cr | 273.82 Cr | 308.13 Cr | 336.75 Cr |
| Less: Accumulated Depreciation | 88.68 Cr | 105.1 Cr | 133.34 Cr | 165.64 Cr |
| Net Block | 134.75 Cr | 168.72 Cr | 174.8 Cr | 171.11 Cr |
| Capital Work in Progress | 17.46 Cr | 30.7 Lk | 12.31 Cr | 58.57 Cr |
| Long Term Loans & Advances | 10.65 Cr | 11.75 Cr | 7.25 Cr | 4.97 Cr |
| Total Non-Current Assets | 162.86 Cr | 180.77 Cr | 194.36 Cr | 234.66 Cr |
| Inventories | 14.64 Cr | 17.38 Cr | 22.62 Cr | 24.69 Cr |
| Work-in Progress | 48.1 Lk | 21.5 Lk | 10.4 Lk | 0 |
| Stores and Spare | 14.15 Cr | 17.16 Cr | 22.52 Cr | 24.69 Cr |
| Sundry Debtors | 73.46 Cr | 76.94 Cr | 79.99 Cr | 87 Cr |
| Debtors more than Six months | 0 | 14.88 Cr | 16.29 Cr | 20.39 Cr |
| Debtors Others | 78.83 Cr | 68.72 Cr | 71.86 Cr | 75.72 Cr |
| Cash and Bank | 6.8 Cr | 11.42 Cr | 39.78 Cr | 25.79 Cr |
| Cash in hand | 4 Lk | 4.8 Lk | 7.6 Lk | 24.9 Lk |
| Balances at Bank | 6.76 Cr | 11.37 Cr | 39.7 Cr | 25.54 Cr |
| Other Current Assets | 11.18 Cr | 11.88 Cr | 13.87 Cr | 13.3 Cr |
| Interest accrued on Investments | 9.4 Lk | 11.5 Lk | 34.2 Lk | 18 Lk |
| Prepaid Expenses | 3.54 Cr | 3.4 Cr | 3.45 Cr | 3.04 Cr |
| Short Term Loans and Advances | 4.47 Cr | 6.75 Cr | 7.4 Cr | 6.82 Cr |
| Advances recoverable in cash or in kind | 1.83 Cr | 4.04 Cr | 4.14 Cr | 3.58 Cr |
| Total Current Assets | 110.54 Cr | 124.36 Cr | 163.66 Cr | 157.6 Cr |
| Net Current Assets (Including Current Investments) | 56.62 Cr | 76.61 Cr | 106.38 Cr | 103.53 Cr |
| Total Assets | 273.39 Cr | 305.13 Cr | 358.01 Cr | 392.25 Cr |
| Contingent Liabilities | 3.14 Cr | 2.44 Cr | 2.49 Cr | 4.98 Cr |
| Total Debt | 30.42 Cr | 19.34 Cr | 14.99 Cr | 19.19 Cr |
| Book Value | 87.92 | 0 | 124.46 | 141.18 |
| Adjusted Book Value | 87.92 | 104.52 | 124.46 | 141.18 |
STANDALONE BALANCE SHEET FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 4.42 Cr | 4.42 Cr | 4.42 Cr | 4.43 Cr |
| Equity - Authorised | 7 Cr | 7 Cr | 7 Cr | 7 Cr |
| Equity - Issued | 4.42 Cr | 4.42 Cr | 4.42 Cr | 4.43 Cr |
| Equity Paid Up | 4.42 Cr | 4.42 Cr | 4.42 Cr | 4.43 Cr |
| Face Value | 2 | 2 | 2 | 2 |
| Total Reserves | 189.9 Cr | 226.33 Cr | 226.33 Cr | 305.15 Cr |
| Securities Premium | 77.37 Cr | 77.37 Cr | 77.37 Cr | 79.19 Cr |
| Profit & Loss Account Balance | 105.53 Cr | 142.17 Cr | 142.17 Cr | 219.42 Cr |
| General Reserves | 8.64 Cr | 8.64 Cr | 8.64 Cr | 8.64 Cr |
| Reserve excluding Revaluation Reserve | 189.9 Cr | 226.33 Cr | 226.33 Cr | 305.15 Cr |
| Shareholder's Funds | 194.32 Cr | 233.65 Cr | 233.65 Cr | 316.29 Cr |
| Secured Loans | 14.34 Cr | 12.27 Cr | 12.27 Cr | 9.07 Cr |
| Term Loans - Banks | 19.01 Cr | 17.91 Cr | 17.91 Cr | 13.84 Cr |
| Term Loans - Institutions | 1.26 Cr | 26.2 Lk | 26.2 Lk | 0 |
| Unsecured Loans | -10.2 Lk | 39 Lk | 39 Lk | 0 |
| Loans - Others | 1.15 Cr | 84.5 Lk | 84.5 Lk | 0 |
| Deferred Tax Assets / Liabilities | -96.6 Lk | -2.07 Cr | -2.07 Cr | -7.8 Cr |
| Deferred Tax Assets | 3.88 Cr | 4.7 Cr | 4.7 Cr | 7.8 Cr |
| Deferred Tax Liability | 2.92 Cr | 2.64 Cr | 2.64 Cr | 0 |
| Other Long Term Liabilities | 3.84 Cr | 5.58 Cr | 5.58 Cr | 5.33 Cr |
| Long Term Provisions | 7.92 Cr | 7.12 Cr | 7.12 Cr | 11.76 Cr |
| Total Non-Current Liabilities | 25.03 Cr | 23.29 Cr | 23.29 Cr | 18.36 Cr |
| Trade Payables | 14.6 Cr | 12.23 Cr | 12.23 Cr | 8.18 Cr |
| Sundry Creditors | 14.6 Cr | 12.23 Cr | 12.23 Cr | 8.18 Cr |
| Other Current Liabilities | 26.36 Cr | 31.42 Cr | 31.42 Cr | 36.84 Cr |
| Advances received from customers | 4.11 Cr | 4.72 Cr | 4.72 Cr | 4.53 Cr |
| Interest Accrued But Not Due | 5.4 Lk | 60,000 | 60,000 | 0 |
| Short Term Borrowings | 8.21 Cr | 0 | 0 | 5.14 Cr |
| Secured ST Loans repayable on Demands | 8.21 Cr | 0 | 0 | 5.14 Cr |
| Working Capital Loans- Sec | 8.21 Cr | 0 | 0 | 5.14 Cr |
| Short Term Provisions | 3.59 Cr | 3.56 Cr | 3.56 Cr | 3.39 Cr |
| Total Current Liabilities | 52.76 Cr | 47.22 Cr | 47.22 Cr | 53.55 Cr |
| Total Liabilities | 272.11 Cr | 304.16 Cr | 304.16 Cr | 388.2 Cr |
| Gross Block | 216.01 Cr | 266.16 Cr | 266.16 Cr | 327.88 Cr |
| Less: Accumulated Depreciation | 88.27 Cr | 104.52 Cr | 104.52 Cr | 164.69 Cr |
| Net Block | 127.74 Cr | 161.64 Cr | 161.64 Cr | 163.19 Cr |
| Capital Work in Progress | 17.29 Cr | 30.7 Lk | 30.7 Lk | 58.57 Cr |
| Non Current Investments | 6.15 Cr | 6.15 Cr | 6.15 Cr | 6.15 Cr |
| Long Term Investment | 6.15 Cr | 6.15 Cr | 6.15 Cr | 6.15 Cr |
| Unquoted | 6.15 Cr | 6.15 Cr | 6.15 Cr | 6.15 Cr |
| Long Term Loans & Advances | 10.49 Cr | 11.46 Cr | 11.46 Cr | 4.86 Cr |
| Total Non-Current Assets | 161.67 Cr | 179.56 Cr | 179.56 Cr | 232.77 Cr |
| Unquoted | 6.15 Cr | 6.15 Cr | 6.15 Cr | 6.15 Cr |
| Inventories | 14.64 Cr | 17.38 Cr | 17.38 Cr | 24.69 Cr |
| Work-in Progress | 48.1 Lk | 21.5 Lk | 21.5 Lk | 0 |
| Stores and Spare | 14.15 Cr | 17.16 Cr | 17.16 Cr | 24.69 Cr |
| Sundry Debtors | 73.2 Cr | 76.92 Cr | 76.92 Cr | 86.34 Cr |
| Debtors more than Six months | 0 | 14.84 Cr | 14.84 Cr | 20.33 Cr |
| Debtors Others | 78.54 Cr | 68.74 Cr | 68.74 Cr | 75.12 Cr |
| Cash and Bank | 6.61 Cr | 11.27 Cr | 11.27 Cr | 24.44 Cr |
| Cash in hand | 3.6 Lk | 4.5 Lk | 4.5 Lk | 24.3 Lk |
| Balances at Bank | 6.58 Cr | 11.22 Cr | 11.22 Cr | 24.19 Cr |
| Other Current Assets | 11.15 Cr | 11.88 Cr | 11.88 Cr | 13.29 Cr |
| Interest accrued on Investments | 9.7 Lk | 11.8 Lk | 11.8 Lk | 18 Lk |
| Prepaid Expenses | 3.53 Cr | 3.4 Cr | 3.4 Cr | 3.04 Cr |
| Short Term Loans and Advances | 4.84 Cr | 7.16 Cr | 7.16 Cr | 6.67 Cr |
| Advances recoverable in cash or in kind | 1.83 Cr | 4.03 Cr | 4.03 Cr | 3.58 Cr |
| Total Current Assets | 110.44 Cr | 124.6 Cr | 124.6 Cr | 155.44 Cr |
| Net Current Assets (Including Current Investments) | 57.67 Cr | 77.38 Cr | 77.38 Cr | 101.88 Cr |
| Total Assets | 272.11 Cr | 304.16 Cr | 304.16 Cr | 388.2 Cr |
| Contingent Liabilities | 3.14 Cr | 2.44 Cr | 2.44 Cr | 5.73 Cr |
| Total Debt | 29.63 Cr | 19.02 Cr | 19.02 Cr | 19.19 Cr |
| Book Value | 87.89 | 0 | 104.37 | 139.64 |
| Adjusted Book Value | 87.89 | 104.37 | 104.37 | 139.64 |
FINANCIAL RATIOS (CONSOLIDATED) FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 9.68 | 18.69 | 21.77 | 18.5 |
| CEPS(Rs) | 20.12 | 29.24 | 35.65 | 33.92 |
| DPS(Rs) | 2 | 2 | 2 | 2 |
| Book NAV/Share(Rs) | 87.92 | 104.52 | 124.46 | 141.18 |
| Tax Rate(%) | 25 | 25.78 | 25.89 | 24.73 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 25.14 | 28.85 | 29.83 | 27.27 |
| EBIT Margin(%) | 14.58 | 20.55 | 21.26 | 17.79 |
| Pre Tax Margin(%) | 13.55 | 20.01 | 20.43 | 17.12 |
| PAT Margin (%) | 10.16 | 14.85 | 15.14 | 12.89 |
| Cash Profit Margin (%) | 21.11 | 23.24 | 24.79 | 23.63 |
| Performance Ratios | ||||
| ROA(%) | 8.25 | 14.29 | 14.53 | 10.93 |
| ROE(%) | 11.66 | 19.43 | 19.02 | 13.94 |
| ROCE(%) | 14.25 | 23.92 | 24.59 | 17.81 |
| Asset Turnover(x) | 0.81 | 0.96 | 0.96 | 0.85 |
| Sales/Fixed Asset(x) | 0.99 | 1.12 | 1.09 | 0.99 |
| Working Capital/Sales(x) | 3.72 | 3.63 | 2.99 | 3.07 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.01 | 0.89 | 0.91 | 1.01 |
| Receivable days | 113.74 | 98.63 | 90 | 95.75 |
| Inventory Days | 27.52 | 20.99 | 22.94 | 27.13 |
| Payable days | 29.61 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 16.63 | 16.86 | 14.44 | 24.04 |
| PCE(x) | 8 | 10.77 | 8.82 | 13.11 |
| Price/Book(x) | 1.83 | 3.01 | 2.52 | 3.15 |
| Yield(%) | 1.24 | 0.63 | 0.64 | 0.45 |
| EV/Net Sales(x) | 1.8 | 2.53 | 2.11 | 3.08 |
| EV/Core EBITDA(x) | 7.06 | 8.62 | 6.82 | 10.78 |
| EV/EBIT(x) | 12.36 | 12.32 | 9.91 | 17.3 |
| EV/CE(x) | 1.39 | 2.31 | 1.87 | 2.89 |
| M Cap / Sales | 1.69 | 2.5 | 2.19 | 3.1 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 16.58 | 32.09 | 14.34 | 0.02 |
| Core EBITDA Growth(%) | 63.15 | 51.97 | 20.33 | -7.68 |
| EBIT Growth(%) | 155.16 | 86.22 | 18.29 | -16.32 |
| PAT Growth(%) | 212.71 | 93.09 | 16.55 | -14.87 |
| EPS Growth(%) | 212.71 | 93.09 | 16.45 | -15.02 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.16 | 0.08 | 0.05 | 0.06 |
| Current Ratio(x) | 2.05 | 2.6 | 2.86 | 2.91 |
| Quick Ratio(x) | 1.78 | 2.24 | 2.46 | 2.46 |
| Interest Cover(x) | 14.16 | 38.17 | 25.57 | 26.67 |
| Total Debt/Mcap(x) | 0.09 | 0.03 | 0.02 | 0.02 |
FINANCIAL RATIOS (STANDALONE) FOR VIMTA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 9.62 | 18.57 | 18.57 | 17.5 |
| CEPS(Rs) | 19.99 | 29.04 | 29.04 | 32.84 |
| DPS(Rs) | 2 | 2 | 2 | 2 |
| Book NAV/Share(Rs) | 87.89 | 104.37 | 104.37 | 139.64 |
| Tax Rate(%) | 25.13 | 25.82 | 25.82 | 24.7 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 25.2 | 28.91 | 28.91 | 26.73 |
| EBIT Margin(%) | 14.62 | 20.6 | 20.6 | 17.15 |
| Pre Tax Margin(%) | 13.58 | 20.06 | 20.06 | 16.47 |
| PAT Margin (%) | 10.17 | 14.88 | 14.88 | 12.4 |
| Cash Profit Margin (%) | 21.14 | 23.27 | 23.27 | 23.27 |
| Performance Ratios | ||||
| ROA(%) | 8.24 | 14.25 | 14.25 | 10.43 |
| ROE(%) | 11.58 | 19.32 | 19.32 | 13.29 |
| ROCE(%) | 14.24 | 23.85 | 23.85 | 17 |
| Asset Turnover(x) | 0.81 | 0.96 | 0.96 | 0.84 |
| Sales/Fixed Asset(x) | 1.01 | 1.14 | 1.14 | 1 |
| Working Capital/Sales(x) | 3.62 | 3.57 | 3.57 | 3.07 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.99 | 0.87 | 0.87 | 1 |
| Receivable days | 114.25 | 99.27 | 99.27 | 96.96 |
| Inventory Days | 27.73 | 21.17 | 21.17 | 27.6 |
| Payable days | 29.18 | 0 | 0 | 0 |
| Valuation Parameters | ||||
| PER(x) | 16.74 | 16.97 | 16.92 | 25.4 |
| PCE(x) | 8.05 | 10.85 | 10.82 | 13.54 |
| Price/Book(x) | 1.83 | 3.02 | 3.01 | 3.18 |
| Yield(%) | 1.24 | 0.63 | 0.64 | 0.45 |
| EV/Net Sales(x) | 1.81 | 2.55 | 2.55 | 3.13 |
| EV/Core EBITDA(x) | 7.08 | 8.67 | 8.65 | 11.19 |
| EV/EBIT(x) | 12.4 | 12.39 | 12.36 | 18.27 |
| EV/CE(x) | 1.39 | 2.32 | 2.31 | 2.92 |
| M Cap / Sales | 1.7 | 2.52 | 2.52 | 3.15 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 15.71 | 32.02 | 32.02 | -0.71 |
| Core EBITDA Growth(%) | 61.96 | 51.82 | 51.82 | -9.65 |
| EBIT Growth(%) | 152.37 | 85.98 | 85.98 | -19.29 |
| PAT Growth(%) | 206.92 | 93.12 | 93.12 | -17.95 |
| EPS Growth(%) | 206.92 | 93.12 | 93.12 | -18.1 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.15 | 0.08 | 0.08 | 0.06 |
| Current Ratio(x) | 2.09 | 2.64 | 2.64 | 2.9 |
| Quick Ratio(x) | 1.82 | 2.27 | 2.27 | 2.44 |
| Interest Cover(x) | 14.1 | 38 | 38 | 25.39 |
| Total Debt/Mcap(x) | 0.08 | 0.03 | 0.03 | 0.02 |
SHARE HOLDING PATTERN FOR VIMTA LABS LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 37.46 | 37.46 | 37.25 | 37.24 | 37.23 | 37.01 | 36.98 | 36.92 | 36.89 | 36.89 |
| FII % | 0.35 | 0.49 | 2.28 | 2.25 | 2.72 | 2.74 | 2.88 | 5.13 | 5.16 | 3.31 |
| DII % | 0.53 | 0.56 | 0.65 | 0.66 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public % | 60.18 | 60.02 | 58.34 | 58.38 | 57.92 | 58.75 | 58.66 | 56.45 | 56.46 | 59.80 |
PEER COMPARISON FOR VIMTA LABS LIMITED
CORPORATE ACTIONS FOR VIMTA LABS
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 11-Jul-2024 | Board Meeting - Quarterly Results | 17-Jul-2024 |
| BSE 21-May-2024 | Book Closure - Rs.2.0000 per share(100%)Final Dividend & A.G.M. | 12-Jul-2024 18-Jul-2024 |
| BSE 21-May-2024 | AGM - Rs.2.0000 per share(100%)Final Dividend & A.G.M. | 18-Jul-2024 18-Jul-2024 |
| BSE 21-May-2024 | Dividend - Rs.2.0000 per share(100%)Final Dividend | |
| BSE 08-May-2024 | Board Meeting - Final Dividend & Audited Results | 18-May-2024 |
| BSE 20-Mar-2024 | Board Meeting - Amalgamation | 30-Mar-2024 |
| BSE 19-Jan-2024 | Board Meeting - Quarterly Results | 31-Jan-2024 |
| BSE 18-Oct-2023 | Board Meeting - Quarterly Results | 30-Oct-2023 |
| BSE 19-Jul-2023 | Board Meeting - Quarterly Results | 28-Jul-2023 |
| BSE 01-Jun-2023 | Book Closure - Rs.2.0000 per share(100%)Final Dividend & A.G.M. | 22-Jun-2023 28-Jun-2023 |
| BSE 01-Jun-2023 | AGM - Rs.2.0000 per share(100%)Final Dividend & A.G.M. | 28-Jun-2023 28-Jun-2023 |
| BSE 03-May-2023 | AGM - Inter alia, approved:- 1. Recommended Dividend of Rs 2 (Rupees two only) per share with face value of Rs.2 each for the financial year 2022-2023; subject to approval of shareholders in their ensuing Annual General Meeting; 2. Recommended appointment of Dr. S P Vasireddi (DIN: 00242288 as the Executive Chairman of the Company, for approval by the shareholders at ensuing Annual General Meeting; and ... | 28-Jun-2023 |
| BSE 03-May-2023 | Dividend - Rs.2.0000 per share(100%)Final Dividend | |
| BSE 24-Apr-2023 | Board Meeting - Final Dividend & Audited Results | 03-May-2023 |
| BSE 13-Jan-2023 | Board Meeting - Quarterly Results | 27-Jan-2023 |
| BSE 17-Oct-2022 | Board Meeting - Quarterly Results | 27-Oct-2022 |
| BSE 13-Jul-2022 | Board Meeting - Quarterly Results | 25-Jul-2022 |
| BSE 30-May-2022 | Book Closure - A.G.M. | 19-Jun-2022 25-Jun-2022 |
| BSE 12-May-2022 | Dividend - Rs.2.0000 per share(100%)Dividend | |
| BSE 12-May-2022 | AGM - Inter alia, approved: 1. Recommended Dividend of Rs 2 (Rupees two only) per share with face value of Rs.2 each for the financial year 2021-2022; subject to approval of shareholders in their ensuing Annual General Meeting; 2. Recommended continuation of the payment of remuneration to Smt. Harita Vasireddi (DIN: 00242512) Managing Director of the Company and revision of payment of remuneration to Sh... | 25-Jun-2022 |
| BSE 02-May-2022 | Board Meeting - Dividend & Audited Results | 12-May-2022 |
| BSE 10-Jan-2022 | Board Meeting - Quarterly Results | 20-Jan-2022 |
| BSE 14-Oct-2021 | Board Meeting - Quarterly Results | 23-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR VIMTA LABS
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 25-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issued duplicate share certificate(s) on 25th October 2024 in lieu of the Original Share Certificate which had been reported lost/misplaced by the shareholder |
| BSE 21-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS ESOP Allotment Committee of the Board of Directors of the Company at their meeting held on 21st October 2024 has allotted 42696 equity shares of face value of Rs.2/-. |
| BSE 11-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended 30th September 2024. |
| BSE 11-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements Completion of Business Transfer Agreement with Thyrocare Technologies Limited. |
| BSE 03-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation in term of Regulation 39(3) of SEBI (LODR) Regulations 2015 - Issue of duplicate share certificates. |
| BSE 03-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding receipt of Information for loss of share certificate. |
| BSE 30-Sep-2024 | Intimation FILE | Closure of Trading Window Intimation for closure of trading window for the second quarter ended 30th September 2024. |
| BSE 11-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding receipt of Information for loss of share certificate. |
| BSE 30-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release- Execution of Business Transfer Agreement |
| BSE 30-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements This is to inform you that the company has entered into Business Transfer Agreement ("BTA") on 30th August 2024 around 11:00 AM with inter-alia Thyrocare Technologies Limited (Thyrocare). By this agreement our company will be transferring and selling its Diagnostics and pathological services business to Thyrocare as a going concern (on slump sale basis). Th said transfer is subject to fulfilment of the Condition Precedent ("CP"). |
| BSE 23-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of schedule of Analysts/ Institutional Investor Meet. |
| BSE 12-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find the enclosed the published newspaper advertisement in Business Standard (English) and Nava Telangana (Telugu) on 12th August 2024 regarding notice of hearing of petition fixed before the NCLT on 23.09.2024 in the matter of Amalgamation of EMTAC Laboratories Pvt Ltd and Vimta labs Limited. |
| BSE 01-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation in terms of Regulation 39(3) of SEBI (LODR) Regulations 2015 - Issue of duplicate share certificates. |
| BSE 29-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Credit Rating Disclosure on Credit Rating. |
| BSE 24-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of the Q1-2025 earning/investor call held on 18th July 2024. |
| BSE 23-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio Recording of the Q1-2025 earnings/investor call held on 18th July 2024. |
| BSE 23-Jul-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding receipt of Information for loss of share certificate. |
| BSE 18-Jul-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Submission of Voting Result and Scrutinizer Report of 34th Annual General Meeting held Thursday 18th July 2024. |
| BSE 18-Jul-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Proceeding of 34th Annual General Meeting (AGM) held on Thursday 18th July 2024. |
| BSE 18-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Standalone and Consolidated Unaudited Financial Results for the first quarter ended 30th June 2024 Published in Financial Express (English) and Nava Telangane (Telugu) on 18th July 2024. |
| BSE 17-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation - 1st Quarter Results - FY - 2024-2025 |
| BSE 17-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release - Unaudited Financial Results - 30th June 2024 |
| BSE 17-Jul-2024 | Outcome FILE | Quarterly Financial Results - 30.06.2024 Standalone & Consolidated Unaudited Financial Results for the 1st Quarter |
| BSE 17-Jul-2024 | Outcome FILE | Board Meeting Outcome for Standalone & Consolidated Unaudited Financial Results Of The 1St Quarter Standalone & Consolidated Unaudited financial results of the 1st Quarter |
| BSE 13-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulation 2018 for the quarter ended 30th June 2024. |
| BSE 12-Jul-2024 | General Announcements FILE | Corporate Action-Updates on Amalgamation/ Merger / Demerger Intimation of exemption order received from Honble National Company Law Tribunal (NCLT) |
| BSE 12-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation We hereby inform you the schedule of Analyst/Investor Conference Call post announcement of Q1 Results for the FY 2024-25 to be held on Thursday 18th July 2024 at 02:30 PM. |
| BSE 11-Jul-2024 | Intimation FILE | Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015 VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve NOTICE is hereby given pursuant to regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 17th July 2024 to consider approve and take on record the standalone unaudited financial results and consolidated unaudited financial results for the first quarter ended 30th June 2024.Further as per the SEBI (Prohibition of Insider Trading) Regulations 2015 and in accordance to the code of conduct of the Company the Trading window closure period has commenced from 01st July 2024 and will remain closed till 48 hours after the announcement of financial results of the company to the stock exchange.Copy of the Notice is available in the companys website i.e. https://vimta.com/notices/ |
| BSE 08-Jul-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation in term of Regulation 39(3) of SEBI (LODR) Regulation 2015 - Issue of duplicate share certificate. |
| BSE 29-Jun-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading Window |
INSIDER TRADING FOR VIMTA LABS
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 23-Jul-2024 28-Aug-2024 | Sell Market | 2,535 @ 0.00 (0.00 %) | Muni Nagendra Prasad Poola |
| BSE 26-Feb-2024 26-Feb-2024 | Sell Market | 10,000 @ 0.00 (0.05 %) | Sujani Vasireddi |
| BSE 23-Feb-2024 23-Feb-2024 | Sell Market | 2,000 @ 0.00 (0.01 %) | Suresh Kumar |
| BSE 15-Nov-2023 15-Nov-2023 | Buy Gift | 1,000,000 @ 0.00 (4.52 %) | Praveena Vasireddi |
| BSE 15-Nov-2023 15-Nov-2023 | Sell Gift | 1,000,000 @ 0.00 (4.52 %) | Sivalinga Prasad Vasireddi |
| BSE 17-Aug-2023 17-Aug-2023 | Sell Market | 18,234 @ 0.00 (0.08 %) | Sujani Vasireddi |
| BSE 14-Aug-2023 14-Aug-2023 | Sell Market | 10,000 @ 0.00 (0.05 %) | Praveena Vasireddi |
| BSE 14-Aug-2023 14-Aug-2023 | Sell Market | 4,766 @ 0.00 (0.02 %) | Sujani Vasireddi |
| BSE 11-Aug-2023 11-Aug-2023 | Sell Market | 2,000 @ 0.00 (0.01 %) | Sujani Vasireddi |
| BSE 09-Aug-2023 10-Aug-2023 | Sell Market | 4,514 @ 0.00 (0.00 %) | Jagadeesh Kodali |
| BSE 21-Nov-2022 21-Nov-2022 | Sell Market | 5,000 @ 0.00 (0.00 %) | Suresh Kumar |
| BSE 01-Nov-2022 02-Nov-2022 | Sell Market | 40,000 @ 0.00 (0.18 %) | RAJYA LAKSHMI VASIREDDI |
BULK BLOCK DEALS FOR VIMTA LABS LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Bulk Block details found | |||
DIVIDEND BY VIMTA LABS LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 11-Jul-2024 | DIVIDEND | 2 |
| 21-Jun-2023 | DIVIDEND | 2 |
| 16-Jun-2022 | DIVIDEND | 2 |
| 25-Jun-2021 | DIVIDEND | 2 |
SPLIT / BONUS BY VIMTA LABS LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed